OIL 9.09% 20.0¢ optiscan imaging limited

Good signs ...., page-608

  1. 5,957 Posts.
    lightbulb Created with Sketch. 959
    Cancer research stands at a critical juncture. While we've made significant strides, disease complexity demands innovative tools to unlock its remaining mysteries. Enter ViewnVivo® by Optiscan, a miniaturized hand-held confocal endomicroscope poised to revolutionize the field. This groundbreaking technology offers unparalleled capabilities to researchers, propelling them deeper into the heart of cancer's intricate biology, and accelerating observational research like never before.
    Beyond the Static Image: Witnessing Cancer's Dynamic Dance
    Traditional imaging methods provide snapshots in time, offering a limited view of the ever-evolving disease processes in cancer. ViewnVivo® disrupts this paradigm by capturing live, in vivo images at submicron resolution. Imagine witnessing tumor growth unfold in real-time, observing the dynamic interplay between individual cells within the tumor microenvironment. This isn't mere observation; ViewnVivo® goes a step further. Its capacity for optical biopsies and 3D reconstruction allows researchers to deconstruct cancer's intricate architecture, illuminating its progression and potential vulnerabilities. This newfound understanding holds immense promise for developing targeted therapies that exploit disease weaknesses.
    Reaching the Unreachable: Accessing Hidden Cancers
    The battle against cancer is often hindered by its ability to hide in complex anatomical regions. The ViewnVivo® miniaturized and flexible probe solves this problem. By providing access to previously unreachable areas, researchers can now study cancers in the breast, GI tract, oral cavity or other organs. This ability to peer into the previously unseen opens a new frontier of discovery, holding immense potential for uncovering new therapeutic targets and informing surgical strategies. With ViewnVivo®, previously inaccessible cancers are no longer hidden fortresses, but battlegrounds laid bare for researchers to explore and conquer.
    Bridging the Gap: Seamless Integration for Streamlined Workflows
    ViewnVivo® isn't intended to operate in isolation. Its design fosters seamless integration into existing research workflows, eliminating disruptions and optimizing efficiency. The device's utility with standard lab equipment like 96-well plates and robotic arms facilitates high-throughput imaging and automated data collection. This translates to researchers being able to analyze numerous samples effortlessly, accelerating the pace of discovery. ViewnVivo® isn’t just provide a powerful tool; it streamlines the research process, allowing researchers to spend less time wrestling with technology and more time unlocking the secrets of cancer.
    The Future of Cancer Research: A New Era of Discovery
    ViewnVivo® by Optiscan represents a significant leap forward in cancer research. It empowers researchers to delve deeper into the intricacies of the disease, unveiling its dynamic nature and hidden complexities. This deeper understanding will undoubtedly fuel the development of new diagnostic tools and therapeutic strategies, bringing us closer to a future where cancer is history. By empowering researchers to ask new questions and explore uncharted territories in new ways, ViewnVivo® paves the way for a new era of discovery in the fight against cancer.
 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
-0.020(9.09%)
Mkt cap ! $167.0M
Open High Low Value Volume
22.0¢ 22.5¢ 20.0¢ $29.60K 142.3K

Buyers (Bids)

No. Vol. Price($)
2 44267 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 13834 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.